Skip to content
Evidence Library
EEvidence Library

Every peptide, graded by the evidence

We read the published studies and we grade each compound by the strength of the evidence behind it. Each profile lists its sources.

Emerging

Early preclinical work. Limited data, or no independent replication.

Moderate

A large preclinical body. Some human data.

Established

Strong human clinical evidence.

We count human trials from ClinicalTrials.gov and published studies from PubMed. We show the count on each profile.

We hold 8 profiles today. We add profiles in order of research volume. Tell us which compound to cover next.

8 profiles

01
Recovery & Healing

BPC-157

Body Protection Compound 157

A synthetic pentadecapeptide studied heavily in preclinical tissue-repair models.

Moderate
02
Recovery & Healing

TB-500

Thymosin Beta-4 fragment

An actin-regulating peptide fragment studied in cell-migration and repair models.

Emerging
03
Metabolic

Semaglutide

GLP-1 receptor agonist

A GLP-1 receptor agonist with extensive human clinical trial data for metabolic endpoints.

Established
04
Growth Hormone

Tesamorelin

GHRH analog

A GHRH analog with FDA-approved clinical indications and strong human data.

Established
05
Growth Hormone

Ipamorelin

GH secretagogue

A selective GH secretagogue studied for its clean receptor profile in preclinical models.

Emerging
06
Longevity

Epithalon

Epitalon

A tetrapeptide studied in telomerase and circadian-regulation models.

Emerging
07
Longevity

GHK-Cu

Copper peptide

A naturally occurring copper-binding tripeptide with dermal-remodeling research.

Moderate
08
Cognitive

Selank

Anxiolytic peptide

A tuftsin-derived peptide studied in anxiety and neuro-immune models.

Emerging